Is less actually more when trying to liberate patients with AKI on dialysis? Read the summary 10 posts and find out
BigPAK or a bundle of balderdash?
Dialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D
Trial by Combat: Do Amino Acids provide PROTECTION to the Kidneys?
Heart-burn and Kidney Churn
🤔 Risk of AIN with PPI/ICI overstated
Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study (Munch, International Journal of Cancer 2023)
🤔 E-alerts in AKI, the ELAIA-2 trial
A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes (Wilson, Nature Communications 2023)
🤔 RCT comparing Cefepime with Pip/Taz and AKI
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial (Quian, JAMA 2023)
CXCL9: A Urinary Marker ExplAINed
Is piperacillin-tazobactam nephrotoxic?
The debate continues, but this time with cystatin-C measurements. Read the #TenTweetNephJC summary here!















